The European Technology Platform for Nanomedicine (ETPN) and the EU-funded consortium, ENATRANS, have launched the second edition of the Nanomedicine Awards to honor the best international nanomedicine innovations for 2015.

The Nanomedicine Awards aim at rewarding projects that have developed innovative solutions based on nanomedicine that can ultimately change the way diseases are treated or diagnosed and that could provide new tools for physicians and large benefits to patients.

Applications for the Nanomedicine Awards are open to companies, academic and private researchers from European and non-European countries. Proposals will be evaluated in two areas: Early clinical stage project Award and Best product / deal Award with applications in diagnostics, therapies or regenerative medicine.

Applications are open until September 15, 2015 at http://nanomedicine-award.com/